Health
FDA Approves Treatment for Chronic Kidney Disease – StreetInsider.com
SILVER SPRING, Md., April 30, 2021 /PRNewswire/ –Â Today, the U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the…
SILVER SPRING, Md., April 30, 2021 /PRNewswire/ – Today, the U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression. Â
“Chronic kidney disease is an important public health issue, and there is a significant unmet need for therapies that slow disease progression and improve…
-
General15 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News19 hours agoBrisbane rising on global rankings, but still behind southern capitals
-
Noosa News19 hours agoWest End icon closes doors
-
General21 hours agoCalls for government to ‘get on with’ CSIRO Ginninderra Experiment Station land sale after three-year delay